Background: : Individuals with advanced HIV infection naïve to antiretroviral therapy represent a special population of patients frequently encountered in clinical practice. They are at high risk of disease progression and death, and their viroimmunologic response following the initiation of highly active antiretroviral therapy may be more incomplete or slower than that of other patients. Infection management in such patients can also be complicated by underlying conditions, comorbidities, and the need for concomitant medications. Aim: : To provide practical guidelines to those clinicians providing care to HIV-infected patients in terms of diagnostic assessment, monitoring, and treatment. Conclusions: : The principals of antiretroviral treatment in asymptomatic naïve patients with advanced HIV infection are the same as those applicable to the general population with asymptomatic HIV infection. Naïve patients with advanced HIV infection and a history of AIDS-defining illnesses urgently need antiretroviral treatment, with the choice of antiretroviral regimen and timetable based on such factors as concomitant treatment and prophylaxis, drug interactions, and potential concomitant drug toxicity. Finally, an adequate counseling program - both before and after HIV-testing - that includes aspects other than treatment adherence monitoring is a crucial step in disease management.

Italian consensus statement on management of HIV-infected individuals with advanced disease naive to antiretroviral therapy / A. Antinori, A. Ammassari, C. Torti, P. Marconi, M. Andreoni, G. Angarano, S. Bonora, A. Castagna, R. Cauda, M. Clerici, A. D'Arminio Monforte, A. De Luca, G. Di Perri, M. Galli, E. Girardi, A. Gori, A. Lazzarin, S. Lo Caputo, F. Mazzotta, F. Montella, C. Mussini, C.F. Perno, M. Puoti, G. Rizzardini, S. Rusconi, V. Vullo, G. Carosi, A. Monforte. - In: INFECTION. - ISSN 0300-8126. - 37:3(2009 Jun), pp. 270-282.

Italian consensus statement on management of HIV-infected individuals with advanced disease naive to antiretroviral therapy

M. Clerici;A. D'Arminio Monforte;M. Galli;A. Gori;C.F. Perno;S. Rusconi;
2009

Abstract

Background: : Individuals with advanced HIV infection naïve to antiretroviral therapy represent a special population of patients frequently encountered in clinical practice. They are at high risk of disease progression and death, and their viroimmunologic response following the initiation of highly active antiretroviral therapy may be more incomplete or slower than that of other patients. Infection management in such patients can also be complicated by underlying conditions, comorbidities, and the need for concomitant medications. Aim: : To provide practical guidelines to those clinicians providing care to HIV-infected patients in terms of diagnostic assessment, monitoring, and treatment. Conclusions: : The principals of antiretroviral treatment in asymptomatic naïve patients with advanced HIV infection are the same as those applicable to the general population with asymptomatic HIV infection. Naïve patients with advanced HIV infection and a history of AIDS-defining illnesses urgently need antiretroviral treatment, with the choice of antiretroviral regimen and timetable based on such factors as concomitant treatment and prophylaxis, drug interactions, and potential concomitant drug toxicity. Finally, an adequate counseling program - both before and after HIV-testing - that includes aspects other than treatment adherence monitoring is a crucial step in disease management.
HEPATITIS-C VIRUS ; PNEUMOCYSTIS-CARINII-PNEUMONIA ; AIDS-RELATED MALIGNANCIES ; LONG-TERM SAFETY ; CD4 CELL COUNTS ; SECONDARY PROPHYLAXIS ; NAIVE PATIENTS ; CYTOMEGALOVIRUS RETINITIS ; INITIAL RESPONSE ; CONTROLLED-TRIAL
Settore MED/17 - Malattie Infettive
Settore MED/04 - Patologia Generale
giu-2009
Article (author)
File in questo prodotto:
File Dimensione Formato  
Consensus Naive, Infection 2009.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 300.12 kB
Formato Adobe PDF
300.12 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/65367
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 8
social impact